TY - JOUR
T1 - Growth properties of SF188/V+ human glioma in rats in vivo observed by magnetic resonance imaging
AU - Grossman, Rachel
AU - Tyler, Betty
AU - Brem, Henry
AU - Eberhart, Charles G.
AU - Wang, Silun
AU - Fu, De Xue
AU - Wen, Zhibo
AU - Zhou, Jinyuan
N1 - Funding Information:
Acknowledgments The authors thank Dr. James M. Gallo (Temple University, Philadelphia, PA, USA; currently Mount Sinai School of Medicine, New York, NY, USA) for providing the glioma xenograft cell lines used in this study. The parental SF188/V-cell line was originally provided by the Brain Tumor Research Center, University of California, San Francisco, CA, USA. Dr. Jianguo Ma and Dr. James M. Gallo, et al. (Temple University, Philadelphia, PA, USA) made the SF188/V? cell model. This study was supported in part by Grants from NIH (EB009112, EB009731, EB015032, and EB015555), by the American Physicians Fellowship (APF) for Medicine in Israel (Grossman), and by the Research Scholar Grants, #116293-RSG-08-119-01-CCE from the American Cancer Society (Tyler).
PY - 2012/12
Y1 - 2012/12
N2 - SF188/V+ is a highly vascular human glioma model that is based on transfection of vascular endothelial growth factor (VEGF) cDNA into SF188/V-cells. This study aims to assess its growth and vascularity properties in vivo in a rat model. Thirty-two adult rats were inoculated with SF188/V+ tumor cells, and, for comparison, five were inoculated with SF188/V-tumor cells. Several conventional magnetic resonance imaging (MRI) sequences were acquired, and several quantitative structural (T2 and T1), functional [isotropic apparent diffusion coefficient (ADC) and blood flow], and molecular [protein and peptide-based amide proton transfer (APT)] MRI parameters were mapped on a 4.7 T animal scanner. In rats inoculated with SF188/V+ tumor cells, conventional T2-weighted images showed a highly heterogeneous tumor mass, and post-contrast T1-weighted images showed a heterogeneous, strong enhancement of the mass. There were moderate increases in T2, T1, and ADC, and large increases in blood flow and APT in the tumor, compared to contralateral brain tissue. Microscopic examination revealed prominent vascularity and hemorrhage in the VEGF-secreting xenografts as compared to controls, and immunohistochemical staining confirmed increased expression of VEGF in tumor xenografts. Our results indicate that the SF188/V+ glioma model exhibits some MRI and histopathology features that closely resemble human glioblastoma.
AB - SF188/V+ is a highly vascular human glioma model that is based on transfection of vascular endothelial growth factor (VEGF) cDNA into SF188/V-cells. This study aims to assess its growth and vascularity properties in vivo in a rat model. Thirty-two adult rats were inoculated with SF188/V+ tumor cells, and, for comparison, five were inoculated with SF188/V-tumor cells. Several conventional magnetic resonance imaging (MRI) sequences were acquired, and several quantitative structural (T2 and T1), functional [isotropic apparent diffusion coefficient (ADC) and blood flow], and molecular [protein and peptide-based amide proton transfer (APT)] MRI parameters were mapped on a 4.7 T animal scanner. In rats inoculated with SF188/V+ tumor cells, conventional T2-weighted images showed a highly heterogeneous tumor mass, and post-contrast T1-weighted images showed a heterogeneous, strong enhancement of the mass. There were moderate increases in T2, T1, and ADC, and large increases in blood flow and APT in the tumor, compared to contralateral brain tissue. Microscopic examination revealed prominent vascularity and hemorrhage in the VEGF-secreting xenografts as compared to controls, and immunohistochemical staining confirmed increased expression of VEGF in tumor xenografts. Our results indicate that the SF188/V+ glioma model exhibits some MRI and histopathology features that closely resemble human glioblastoma.
KW - APT imaging
KW - Angiogenesis
KW - Brain tumor
KW - Glioma
KW - MRI
KW - SF188/V+
UR - http://www.scopus.com/inward/record.url?scp=84871337974&partnerID=8YFLogxK
U2 - 10.1007/s11060-012-0974-5
DO - 10.1007/s11060-012-0974-5
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 23011120
AN - SCOPUS:84871337974
SN - 0167-594X
VL - 110
SP - 315
EP - 323
JO - Journal of Neuro-Oncology
JF - Journal of Neuro-Oncology
IS - 3
ER -